Literature DB >> 12084347

Cytoplasmic localization of wild-type p53 in glioblastomas correlates with expression of vimentin and glial fibrillary acidic protein.

Olivier Sembritzki1, Christian Hagel, Katrin Lamszus, Wolfgang Deppert, Wolfgang Bohn.   

Abstract

Cytoplasmic accumulation of wild-type p53 in tumor cells indicates that the tumor suppressor is inactive with regard to growth suppressive functions. Whether this occurs randomly during tumor development or characterizes a certain tumor cell subset is not known. Here we assayed primary glioblastomas for expression and subcellular localization of p53 and determined a correlation with expression of intermediate filament proteins characterizing glial cell development. Sixty-nine percent of the tumors were p53 positive in immunohistochemistry. A significant number of tumors (23%) accumulated wild-type p53 in the cytoplasm, which correlated with the presence of vimentin and glial fibrillary acidic protein, except for 1 case. Tumors with exclusive nuclear p53 contained none or only one of these intermediate filament proteins. In an alternative approach, tumors positive for glial fibrillary acidic protein were screened for expression of p53 and vimentin. Thirty-eight percent of these tumors showed cytoplasmic p53, and all of those also expressed vimentin. Tumors with only nuclear p53 were vimentin negative, except for 1 case. No mutation was detected in p53 exons 5 to 8 in tumors with cytoplasmic p53, suggesting that they express wild-type p53. The data indicate that a cytoplasmic accumulation of wild-type p53 in human primary glioblastomas correlates with a certain intermediate filament protein expression, suggesting that it identifies a certain subset of tumors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12084347      PMCID: PMC1920636          DOI: 10.1093/neuonc/4.3.171

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  13 in total

1.  A shift from nuclear to cytoplasmic breast cancer metastasis suppressor 1 expression is associated with highly proliferative estrogen receptor-negative breast cancers.

Authors:  Natalya Frolova; Mick D Edmonds; Thomas M Bodenstine; Robert Seitz; Martin R Johnson; Rui Feng; Danny R Welch; Andra R Frost
Journal:  Tumour Biol       Date:  2009-07-16

2.  Impaired p53 binding to importin: a novel mechanism of cytoplasmic sequestration identified in oxaliplatin-resistant cells.

Authors:  E Komlodi-Pasztor; S Trostel; D Sackett; M Poruchynsky; T Fojo
Journal:  Oncogene       Date:  2009-07-06       Impact factor: 9.867

3.  Expression of glucose transporter 1 is associated with loss of heterozygosity of chromosome 1p in oligodendroglial tumors WHO grade II.

Authors:  Florian Stockhammer; Andreas von Deimling; Michael Synowitz; Cristiane Blechschmidt; Frank K H van Landeghem
Journal:  J Mol Histol       Date:  2008-08-26       Impact factor: 2.611

4.  Nuclear and cytoplasmic p53 suppress cell invasion by inhibiting respiratory complex-I activity via Bcl-2 family proteins.

Authors:  Eun Mi Kim; Jong Kuk Park; Sang-Gu Hwang; Wun-Jae Kim; Zheng-Gang Liu; Sang Won Kang; Hong-Duck Um
Journal:  Oncotarget       Date:  2014-09-30

5.  Investigation of platinum nanoparticle properties against U87 glioblastoma multiforme.

Authors:  Marta Kutwin; Ewa Sawosz; Slawomir Jaworski; Mateusz Hinzmann; Mateusz Wierzbicki; Anna Hotowy; Marta Grodzik; Anna Winnicka; Andre Chwalibog
Journal:  Arch Med Sci       Date:  2016-03-31       Impact factor: 3.318

6.  Characterization of a panel of monoclonal antibodies recognizing specific epitopes on GFAP.

Authors:  Ni-Hsuan Lin; Albee Messing; Ming-Der Perng
Journal:  PLoS One       Date:  2017-07-10       Impact factor: 3.240

7.  The Effect of Sodium Valproate on the Glioblastoma U87 Cell Line Tumor Development on the Chicken Embryo Chorioallantoic Membrane and on EZH2 and p53 Expression.

Authors:  Dovilė Kavaliauskaitė; Donatas Stakišaitis; Justė Martinkutė; Lina Šlekienė; Arūnas Kazlauskas; Ingrida Balnytė; Vaiva Lesauskaitė; Angelija Valančiūtė
Journal:  Biomed Res Int       Date:  2017-05-31       Impact factor: 3.411

Review 8.  Intermediate Filaments as Effectors of Cancer Development and Metastasis: A Focus on Keratins, Vimentin, and Nestin.

Authors:  Pooja Sharma; Sarah Alsharif; Arwa Fallatah; Byung Min Chung
Journal:  Cells       Date:  2019-05-23       Impact factor: 6.600

9.  Identification of a subunit of NADH-dehydrogenase as a p49/STRAP-binding protein.

Authors:  Xiaomin Zhang; Gohar Azhar; Scott Helms; Ying Zhong; Jeanne Y Wei
Journal:  BMC Cell Biol       Date:  2008-01-29       Impact factor: 4.241

10.  Mutant, wild type, or overall p53 expression: freedom from clinical progression in tumours of astrocytic lineage.

Authors:  F S Pardo; D W Hsu; R Zeheb; J T Efird; P G Okunieff; D M Malkin
Journal:  Br J Cancer       Date:  2004-11-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.